TECH presents this Professional Master's Degree as a unique opportunity to update your obstetric knowledge through a 100% online, multidisciplinary and intensive academic experience"

The difficulties that can arise during pregnancy, childbirth and the postpartum period are diverse, and on many occasions the midwife can avoid them or, at least, reduce the level of damage caused to the mother and the baby, through an up to date and specialized nursing practice in each case. In recent decades, intervention protocols in this type of context have evolved considerably, making clinical activity safer and more comfortable for patients. Thanks to this, it is now possible to carry out prenatal treatments in women carrying infectious bacteria, establish early diagnostic guidelines in ectopic gestations or motivate pulmonary and neurological maturation in premature neonates, among other things.  

Based on this, it is a clinical area in constant change, implementing new techniques and strategies. That is why TECH, in its commitment to the health professions, has developed a comprehensive program through which specialists in this field can be updated on the recommended clinical management of the different pathologies that may arise during pregnancy. For this purpose, you will have 1,500 hours of diverse material with which you will be able to delve into the latest issues related to risk gestation, congenital fetal defects and prenatal diagnosis, among others.  

On the other hand, in this program participates a prestigious International Guest Director who has an outstanding experience in the Obstetrics sector and will give 10 exhaustive Masterclasses. Therefore, it is a perfect academic experience to implement the most innovative strategies and clinical techniques in the obstetric sector, attending an update of your knowledge in a 100% online way. This will allow you to work on it without schedules or face-to-face classes, since the Virtual Campus of this Professional Master's Degree is compatible with any device with an Internet connection, so you can connect whenever you want and from wherever you want.  

With this program you will delve into the pathologies of pregnancy by the hand of a renowned International Guest Director, who will give 10 very complete Masterclasses" 

This Professional Master’s Degree in Pregnancy Pathologies for Midwives contains the most complete and up-to-date scientific program on the market. The most important features include: 

• The development of practical cases presented by experts in Nursing Obstetrics
• The graphic, schematic, and practical contents with which they are created, provide scientific and practical information on the disciplines that are essential for professional practice
• Practical exercises where the self-assessment process can be carried out to improve learning
• Its special emphasis on innovative methodologies
• Theoretical lessons, questions to the expert, debate forums on controversial topics, and individual reflection assignments
• Content that is accessible from any fixed or portable device with an Internet connection

In the Virtual Campus you will find 1,500 hours of the best theoretical, practical and additional material, selected exclusively for this program and designed based on the latest developments in the field of Obstetric Nursing"

The program’s teaching staff includes professionals from the sector who contribute their work experience to this educational program, as well as renowned specialists from leading societies and prestigious universities.

The multimedia content, developed with the latest educational technology, will provide the professional with situated and contextual learning, i.e., a simulated environment that will provide immersive education programmed to learn in real situations.

This program is designed around Problem-Based Learning, whereby the professional must try to solve the different professional practice situations that arise during the academic year For this purpose, the students will be assisted by an innovative interactive video system created by renowned and experienced experts.

Looking for a program to update you on the legal termination of pregnancy? With this program you will be able to delve into the specifics to be taken into account, so that you can guide your patients in the right way"

You will be able to implement in your practice the most effective therapeutic strategies related to the prevention of psychological problems during the postpartum period, such as postpartum depression"

This Professional Master's Degree has been designed by TECH based on 3 main criteria: the immediate actuality of the Obstetric Nursing sector, the professional guidelines of the teaching team and the innovative and effective Relearningmethodology. Thanks to this, it has been possible to create an academic experience through which the professional will be able to catch up without having to invest extra time in memorizing. In addition, you will have hundreds of hours of diverse additional material with which you will be able to contextualize the syllabus and delve in a personalized way in the different sections of the same. All this in a 100% online way, without schedules or face-to-face classes.  

The best program to work on the most frequent obstetric accidents and the strategies for their prevention based on the most innovative and effective safety protocols"

Module 1. Concept of risk gestation. First trimester bleeding. Congenital Fetal Defects. Prenatal Diagnosis

1.1. Addressing High-risk Pregnancies

1.1.1. Sociodemographic Risk

1.1.1.1. Adolescent Pregnancy. Special considerations
1.1.1.2. Mother with Drug Dependency Problems

1.1.1.2.1. Principles of DrugInduced Teratogenesis
1.1.1.2.2. Alcohol
1.1.1.2.3. Cocaine
1.1.1.2.4. Heroin
1.1.1.2.5. Other drugs: Marijuana, Cannabis

1.1.2. Occupational Risk in Pregnancy. Ergonomics. Radiation Exposure
1.1.3. Risks to Reproductive Health.
1.1.4. Current Gestational Risk
1.1.5. Medical Risk

1.2. Miscarriage

1.2.1. Definition and Epidemiology
1.2.2. Main Causes of Miscarriage
1.2.3. Clinical Forms of Abortion

1.2.3.1. Threat of Abortion
1.2.3.2. Abortion in Progress
1.2.3.3. Complete Abortion
1.2.3.4. Incomplete Abortion
1.2.3.5. Deferred Abortion.
1.2.3.6. Repeated Abortions: Concept and Approach

1.2.4. Diagnosis

1.2.4.1. Medical History
1.2.4.2. Physical Examination
1.2.4.3. Ultrasound
1.2.4.4. Determination of B-hCG

1.2.5. Treatment of Spontaneous Abortion

1.2.5.1. Medical Treatment
1.2.5.2. Surgical Management

1.2.6. Complications

1.2.6.1. Sepsis or Septic Abortion
1.2.6.2. Hemorrhage and Disseminated Intravascular Coagulation (DIC)

1.2.7. Postabortion Care.

1.3. Ectopic or Extrauterine Pregnancy

1.3.1. Definition and Risk Factors
1.3.2. Clinical Symptoms
1.3.3. Clinical and Ultrasound Diagnosis
1.3.4. Types of Extrauterine Gestation: Tubal, Ovarian, Abdominal, etc.
1.3.5. Therapeutic Management and Aftercare

1.4. Gestational Trophoblastic Disease

1.4.1. Concept 
1.4.2. Clinical forms of Hydatidiform Mole

1.4.2.1. Partial Mole
1.4.2.2. Complete Mole

1.4.3. Clinical forms of Trophoblastic Neoplasia

1.4.3.1. Invasive Mole and Placental Bed Tumor
1.4.3.2. Choriocarcinoma

1.4.4. Clinical and Ultrasound Diagnosis
1.4.5. Treatment
1.4.6. Aftercare and Complications

1.5. Congenital fetal defects due to genetic causes

1.5.1. Types of Chromosome Abnormalities

1.5.1.1. Aneuploidies
1.5.1.2. Structural Abnormalities.
1.5.1.3. Sexrelated Disorders.

1.5.2. Prenatal Diagnostic Techniques. Inclusion Criteria

1.5.2.1. Invasive Techniques
1.5.2.2. Non-Invasive Techniques

1.5.3. Genetic Counseling

1.6. Congenital Fetal Defects Secondary to Infections: TORCH.I

1.6.1. Toxoplasma

1.6.1.1. Etiologic Agent, Clinic and Epidemiology
1.6.1.2. Prevention
1.6.1.3. Diagnosis
1.6.1.4. Treatment
1.6.1.5. Congenital Toxoplasma Infection

1.6.2. Rubella

1.6.2.1. Etiologic Agent, Clinic and Epidemiology
1.6.2.2. Prevention and Vaccination
1.6.2.3. Diagnosis
1.6.2.4. Treatment
1.6.2.5. Congenital rubella infection

1.7. Congenital Fetal Defects Secondary to Infections: TORCH.II

1.7.1. Cytomegalovirus

1.7.1.1. Etiologic Agent, Clinic and Epidemiology
1.7.1.2. Prevention
1.7.1.3. Diagnosis
1.7.1.4. Treatment
1.7.1.5. Congenital Cytomegalovirus Infection

1.7.2. Chickenpox

1.7.2.1. Etiologic Agent, Clinic and Epidemiology
1.7.2.2. Prevention and Vaccination
1.7.2.3. Diagnosis
1.7.2.4. Treatment
1.7.2.5. Congenital Chickenpox Infection
1.7.2.6. Chickenpox Complications in Mothers

1.8. Congenital Fetal Defects Secondary to Infections: TORCH.III

1.8.1. Herpes Simplex Virus

1.8.1.1. Etiologic Agent, Clinic and Epidemiology
1.8.1.2. Prevention
1.8.1.3. Diagnosis
1.8.1.4. Treatment
1.8.1.5. Congenital Herpes Simplex Infection

1.8.2. Syphilis

1.8.2.1. Etiologic Agent, Clinic and Epidemiology
1.8.2.2. Prevention
1.8.2.3. Diagnosis
1.8.2.4. Treatment
1.8.2.5. Congenital syphilis

1.9. Other Infections that cause Fetal Problems

1.9.1. Parvovirus B19

1.9.1.1. Etiologic Agent, Clinic and Epidemiology
1.9.1.2. Prevention
1.9.1.3. Diagnosis
1.9.1.4. Treatment
1.9.1.5. Congenital parvovirus Infection

1.9.2. Listeria

1.9.2.1. Etiologic Agent, Clinic and Epidemiology
1.9.2.2. Prevention and Vaccination
1.9.2.3. Diagnosis
1.9.2.4. Treatment
1.9.2.5. Congenital Listeria Infection

1.10. HIV and Gestation

1.10.1. Epidemiology
1.10.2. Gestational Screening and Diagnosis
1.10.3. Clinical Management and Treatment
1.10.4. Delivery of an HIV-positive Woman
1.10.5. Neonatal Care and Vertical Infection

Module 2. Pregnant Woman with Pathology derived from the Digestive System

2.1. Neurovegetative Disorders:

2.1.1. Appetite Disorders
2.1.2. Sialorrhea
2.1.3. Nausea and Vomiting

2.2. Hyperemesis Gravidarum:

2.2.1. Concept
2.2.2. Etiopathogenesis
2.2.3. Clinical Manifestations
2.2.4. Diagnosis
2.2.5. Treatment and Care

2.3. Mouth Conditions

2.3.1. Cavities During Pregnancy
2.3.2. Epulis Gravidarum
2.3.3. Gingivitis
2.3.4. Perimylolysis
2.3.5. Xerostomia

2.4. Pyrosis and Peptic Ulcers in Pregnant Women

2.4.1. Concept
2.4.2. Effect of Pregnancy on Heartburn and Peptic Ulcers
2.4.3. Treatment and Hygienic Precautions

2.5. Constipation in Pregnancy

2.5.1. Definition: ROMA criteria
2.5.2. Etiology
2.5.3. Diagnosis
2.5.4. Treatment

2.5.4.1. Non-Pharmacological Treatment
2.5.4.2. Medical Treatment

2.6. Inflammatory Bowel Disease

2.6.1. Crohn's Disease

2.6.1.1. Preconception Counseling
2.6.1.2. Impact of Gestation on the Disease
2.6.1.3. Diagnosis during Pregnancy
2.6.1.4. Treatment

2.6.2. Ulcerative Colitis

2.6.2.1. Preconception Counseling
2.6.2.2. Impact of Gestation on the Disease
2.6.2.3. Diagnosis during Pregnancy
2.6.2.4. Treatment

2.7. Appendicitis and Intestinal Obstruction

2.7.1. Acute Appendicitis

2.7.1.1. Concept
2.7.1.2. Special Diagnostic Considerations in Pregnancy
2.7.1.3. Treatment

2.7.2. Intestinal Obstruction

2.7.2.1. Concept
2.7.2.2. Special Diagnostic Considerations in Pregnancy
2.7.2.3. Treatment

2.8. Gallbladder and Liver Pathologies

2.8.1. Cholecystitis

2.8.1.1. Special Considerations and Management in Gestation

2.8.2. Colelitiasis

2.8.2.1. Special Considerations and Management in Gestation

2.8.3. Fatty liver or acute liver degeneration

2.8.3.1. Definition and Aetiology
2.8.3.2. Clinical Symptoms
2.8.3.3. Diagnosis
2.8.3.4. Treatment

2.9. Intrahepatic Cholestasis of Pregnancy

2.9.1. Concept
2.9.2. Clinical Symptoms
2.9.3. Diagnosis
2.9.4. Treatment
2.9.5. Fetal Impact and Prognosis

2.10. Chronic viral hepatitis and Gestation

2.10.1. Hepatitis B

2.10.1.1. Epidemiology
2.10.1.2. Diagnosis and Screening
2.10.1.3. Clinical Management
2.10.1.4. Delivery of an HIV-positive Woman.
2.10.1.5. Neonatal Care and Vertical Infection

2.10.2. Hepatitis C:

2.10.2.1. Epidemiology
2.10.2.2. Diagnosis and Screening
2.10.2.3. Clinical Management
2.10.2.4. Delivery of an HIV-positive Woman.
2.10.2.5. Neonatal Care and Vertical Infection

2.11. Pancreas

2.11.1. Acute Pancreatitis in Pregnancy

2.11.1.1. Definition and Risk Factors
2.11.1.2. Clinical Symptoms
2.11.1.3. Treatment

Module 3. Pregnant with Hematological and Cardiac Problems

3.1. Gestational Anemia

3.1.1. Concept
3.1.2. Etiopathogenesis and  the Effect on the Fetus
3.1.3. Types of Anemias

3.1.3.1. Microcytic Anemia
3.1.3.2. Normocytic Anemia
3.1.3.3. Macrocytic Anemia

3.1.4. Treatment and Prophylaxis
3.1.5. Other Forms of Anemia

3.1.5.1. Faciform or Sickle Cell Anemia
3.1.5.2. Thalassemia.

3.2. Thrombocytopenia

3.2.1. Essential Trombopenia in Pegnancy

3.2.1.1. Causes and Incidence
3.2.1.2. Diagnosis
3.2.1.3. Obstetric Behavior

3.2.2. Idiopathic Thrombocytopenic Purpura

3.2.2.1. Causes and Incidence
3.2.2.2. Diagnosis
3.2.2.3. Obstetric Behavior

3.2.3. Alloimmune Neonatal Thrombopenia

3.2.3.1. Causes and Incidence
3.2.3.2. Diagnosis
3.2.3.3. Obstetric Behavior

3.2.4. Thrombopenia Associated with Hypertensive States of Pregnancy
3.2.5. Therapeutic Management of Thrombopenias in Pregnancy
3.2.6. Therapeutic Management of the Newborn of a Mother with Thrombopenia

3.3. Coagulation Problems

3.3.1. Von Willebrand Disease

3.3.1.1. Definition and Epidemiology
3.3.1.2. Considerations in Childbirth

3.3.2. Hemophilia

3.3.2.1. Definition and Epidemiology
3.3.2.2. Types

3.3.2.2.1. Hemophilia A.
3.3.2.2.2. Hemophilia B.

3.3.2.3. Chromosomal Inheritance Patterns of Hemophilia
3.3.2.4. Considerations in Childbirth

3.4. Varicose Syndrome

3.4.1. Definition and Pathophysiology
3.4.2. Clinical Symptoms
3.4.3. Diagnosis
3.4.4. Hemorrhoids
3.4.5. Vulvar Varicose Veins

3.5. Perinatal Hemolytic Disease

3.5.1. Concept 
3.5.2. Pathophysiology
3.5.3. Rh Isoimmunization
3.5.4. ABO Isoimmunization

3.6. Thromboembolic Disease in Pregnancy and Postpartum: Deep Vein Thrombosis and Pulmonary Thromboembolism

3.6.1. Aetiopathogenesis and Risk Factors
3.6.2. Treatment

3.7. Gestational Heart Disease. Cardiac Exploration in Pregnancy

3.7.1. Cardiac Modification in Pregnancy
3.7.2. Epidemiology of Cardiac Pathology in Pregnancy
3.7.3. Risk Classification of Gestational heart Disease
3.7.4. Preconception Counseling for Pregnant Women with Heart Disease
3.7.5. Situations that Hinder Gestation
3.7.6. Management and Choice of Delivery Method

3.8. Pregnant Women with Valvular Heart Disease

3.8.1. Mitral Senosis
3.8.2. Aortic Stenosis
3.8.3. Mitral Insufficiency
3.8.4. Aortic Insufficiency
3.8.5. Tricuspid insufficiency
3.8.6. Valve Prosthesis

3.9. Arrhythmias in Pregnancy

3.9.1. Paroxysmal Supraventricular Tachycardia
3.9.2. Atrial Fibrillation
3.9.3. Ventricular Arrhythmias
3.9.4. Bradyarrhythmias

3.10. Pregnant Women with Congenital Cardiac Pathology

3.10.1. Tetralogy of Fallot
3.10.2. Coarctation of Aorta
3.10.3. Marfan Syndrome
3.10.4. Single Ventricle
3.10.5. Fontan.
3.10.6. Pregnant Women with Cardiac Transplants

Module 4. Pregnant with neurological, musculoskeletal, dermatological and autoimmune problems

4.1. Epilepsy

4.1.1. Clinical Management and Treatment Compatible with Gestation: Preconception Counseling
4.1.2. Effects of Epilepsy on Pregnancy
4.1.3. Effects of Pregnancy on Epilepsy
4.1.4. Crisis Management during Childbirth
4.1.5. Newborns of Epileptic Mothers: Malformations and Congenital Anomalies

4.2. Multiple Sclerosis (MS)

4.2.1. Effects of MS on Pregnancy
4.2.2. Effects of Pregnancy on MS
4.2.3. Clinical Management during Gestation and Pharmacotherapy
4.2.4. Clinical Management during Labor
4.2.5. The Postpartum Period in Women with Multiple Sclerosis

4.3. Peripheral Neuropathies

4.3.1. Carpal Tunnel Syndrome
4.3.2. Radiculopathies: Lumbalgias and Sciatalgias
4.3.3. Herniated Disc
4.3.4. Bell’s Palsy
4.3.5. Meralgia Paresthetica
4.3.6. Cyphoscoliosis

4.4. Spinal Cord Injuries

4.4.1. Clinical Management of Women with a Spinal Cord Injury during Pregnancy
4.4.2. Clinical Management during Labor. Epidural Analgesia.
4.4.3. Specific Considerations during the Postpartum Period

4.5. Other Neurological Pathologies present during Gestation

4.5.1. Migraine and headaches
4.5.2. Guillain-Barré Syndrome
4.5.3. Myasthenia Gravis
4.5.4. Cerebrovascular Diseases
4.5.5. Brain Neoplasms

4.6. Dermatological Problems during Pregnancy

4.6.1. Dermatological Changes during Pregnancy

4.6.1.1. Stretch Marks
4.6.1.2. Pregnancy Hyperpigmentation: Melasma Gravidarum and Nevus

4.6.2. Vascular Changes

4.6.2.1. Spider Veins
4.6.2.2. Palmar Erythema
4.6.2.3. Haemangiomas

4.7. Specific Dermatopathologies of Pregnancy

4.7.1. Herpes Gestationis

4.7.1.1. Clinical Symptoms
4.7.7.2. Diagnosis
4.7.1.3. Differential Diagnosis
4.7.1.4. Prognosis
4.7.1.5. Treatment

4.7.2. Impetigo Herpetiformis

4.7.2.1. Clinical Symptoms
4.7.2.2. Diagnosis
4.7.2.3. Differential Diagnosis
4.7.2.4. Prognosis
4.7.2.5. Treatment

4.7.3. Prurigo Gestationis

4.7.3.1. Clinical Symptoms
4.7.3.2. Diagnosis
4.7.3.3. Differential Diagnosis
4.7.3.4. Prognosis
4.7.3.5. Treatment

4.7.4. Papular Dermatosis of Pregnancy

4.7.4.1. Clinical Symptoms
4.7.4.2. Diagnosis
4.7.4.3. Differential Diagnosis
4.7.4.4. Prognosis
4.7.4.5. Treatment

4.7.5. Polymorphous Rash in Pregnancy

4.7.5.1. Clinical Symptoms
4.7.5.2. Diagnosis
4.7.5.3. Differential Diagnosis
4.7.5.4. Prognosis
4.7.5.5. Treatment

4.8. Systemic Lupus Erythematosus and Pregnancy

4.8.1. Preconception Check-up
4.8.2. Gestation control

4.8.2.1. First Trimester
4.8.2.2. Second Trimester
4.8.2.3. Third Trimester

4.8.3. Childbirth and Postpartum

4.9. Antiphospholipid Syndrome (APS)

4.9.1. Concept 
4.9.2. Pregestational Monitoring of Women with APS
4.9.3. Gestational control of the woman with PAS
4.9.4. Treatment
4.9.5. Childbirth and Postpartum

4.10. Rheumatoid Arthritis

4.10.1. Concept
4.10.2. How Rheumatoid Arthritis affects Gestation
4.10.3. How Gestation affects Rheumatoid Arthritis
4.10.4. Treatment

Module 5. Pregnant with Respiratory and Urological/Renal Problems. Tropical and Subtropical Diseases

5.1. Bronquial Asthma.

5.1.1. Concept
5.1.2. Course of bronchial asthma during pregnancy
5.1.3. Treatment
5.1.4. Asthmatic Crisis and Clinical Management
5.1.5. Observations in the delivery of a pregnant woman with bronchial asthma

5.2. Community-acquired Pneumonia and Aspiration Pneumonia

5.2.1. Etiology
5.2.2. Treatment
5.2.3. Specific Factors during Gestation
5.2.4. Newborn from a Mother with Pneumonia

5.3. Influenza

5.3.1. Etiology
5.3.2. Prevention
5.3.3. Pregnancy Issues
5.3.4. Treatment
5.3.5. Criteria for Hospitalization
5.3.6. Newborn from a Mother with flu

5.4. Asymptomatic Bacteriuria

5.4.1. Concept
5.4.2. Etiology
5.4.3. Diagnostic Criteria
5.4.4. Treatment

5.5. Acute Cystitis and Urethral Syndrome

5.5.1. Concept
5.5.2. Etiology
5.5.3. Diagnostic Criteria
5.5.4. Treatment
5.5.5. Monitoring

5.6. Acute Pyelonephritis

5.6.1. Concept
5.6.2. Clinical Symptoms
5.6.3. Diagnosis
5.6.4. Treatment
5.6.5. Admission and Discharge Criteria
5.6.6. Complications

5.7. Obstructive Uropathy

5.7.1. Concept
5.7.2. Clinical Symptoms
5.7.3. Exploration and Specialized Tests
5.7.4. Diagnosis
5.7.5. Treatment
5.7.6. Complications

5.8. Renal Transplantation and Gestation

5.8.1. Effects of Transplantation on Pregnancy
5.8.2. Effects of Pregnancy on Transplants
5.8.3. Considerations during Labor, Postpartum and Lactation

5.9. Tropical and Subtropical Diseases I

5.9.1. Zika

5.9.1.1. Epidemiology
5.9.1.2. Transmission
5.9.1.3. Clinical Symptoms
5.9.1.4. Diagnosis
5.9.1.5. Fetal impact and congenital Zika infection
5.9.1.6. Treatment and Prevention

5.9.2. Ebola

5.9.2.1. Epidemiology
5.9.2.2. Transmission
5.9.2.3. Clinical Symptoms
5.9.2.4. Diagnosis
5.9.2.5. Effects on the Fetus
5.9.2.6. Treatment and Prevention

5.9.3. Chagas Disease

5.9.3.1. Epidemiology
5.9.3.2. Transmission
5.9.3.3. Clinical Symptoms
5.9.3.4. Diagnosis
5.9.3.5. Effects on the Fetus
5.9.3.6. Treatment and Prevention

5.10. Tropical and Subtropical Diseases II

5.10.1. Dengue

5.10.1.1. Epidemiology
5.10.1.2. Transmission
5.10.1.3. Clinical Symptoms
5.10.1.4. Diagnosis
5.10.1.5. Effects on the Fetus
5.10.1.6. Treatment and Prevention

5.10.2. Malaria

5.10.2.1. Epidemiology
5.10.2.2. Transmission
5.10.2.3. Clinical Symptoms
5.10.2.4. Diagnosis
5.10.2.5. Effects on the Fetus
5.10.2.6. Treatment and Prevention

5.10.3. Chikungunya

5.10.3.1. Epidemiology
5.10.3.2. Transmission
5.10.3.3. Clinical Symptoms
5.10.3.4. Diagnosis
5.10.3.5. Effects on the Fetus
5.10.3.6. Treatment and Prevention

Module 6. Pathology of Fetal Growth and Gestational Duration. Premature Labor and Multiple Gestation. Pulmonary and Neurological Maturity

6.1. Intrauterine Growth Restriction (IGR)

6.1.1. Concept 
6.1.2. Pathogenesis and Etiological Factors
6.1.3. Prediction
6.1.4. Diagnosis and Classification
6.1.5. Differential Diagnosis with Small Fetus for Gestational Age (SGAF)
6.1.6. Treatment and Completion of the Gestation

6.2. Fetal Macrosomia

6.2.1. Concept
6.2.2. Risk Factors
6.2.3. Obstetric Follow-up and Control
6.2.4. Completion of pregnancy
6.2.5. Maternal and Fetal Complications

6.3. Chronologically Prolonged Gestation

6.3.1. Concept
6.3.2. Etiology and Prevention
6.3.3. Fetal Complications
6.3.4. Obstetric Behavior
6.3.5. Induction in Week 41 Vs. Week 42

6.4. Premature birth

6.4.1. Threat of Premature Delivery

6.4.1.1. Definition and Risk Factors
6.4.1.2. Diagnosis: Ultrasound and Fibronectin test
6.4.1.3. Obstetric management and tocolytic treatment

6.4.2. Route of delivery in premature fetus and specific considerations

6.5. Cervical incompetence and cerclage

6.5.1. Cervical incompetence concept
6.5.2. Signs of Cervical Cerclage
6.5.3. Cerclage Techniques
6.5.4. Pre- and Post-cerclage Considerations.
6.5.5. Complications
6.5.6. Cerclage Removal

6.6. Suspected Chorioamnionitis and Clinical Chorioamnionitis

6.7.1. Definition of Chorioamnionitis
6.7.2. Criteria for Suspecting Chorioamnionitis
6.7.3. Diagnosis
6.7.4. Treatment
6.7.5. Specific Considerations in Childbirth

6.7. Multiple Gestation

6.7.1. Concept and Classification
6.7.2. Fetal and Maternal Complications
6.7.3. Diagnosis and Determination of Chorionicity
6.7.4. Prenatal Diagnosis and Screening of Chromosomopathies
6.7.5. Gestational Screening
6.7.6. End of Gestation and Delivery Route

6.8. Feto-Fetal Transfusion Syndrome

6.8.1. Definition and Pathophysiology
6.8.2. Diagnostic Criteria
6.8.3. Differential Diagnosis
6.8.4. Treatment

6.8.4.1. Technique of Laser Photocoagulation of Vascular Communications
6.8.4.2. Subsequent monitoring

6.9. Corticosteroid Therapy to Accelerate Fetal Lung Maturation

6.9.1. Concept
6.9.2. Indications
6.9.3. Contraindications
6.9.4. Dosages
6.9.5. Specific Factors according to Gestational Age
6.9.6. Special Situations

6.10. Magnesium Sulfate as a Fetal Neuroprotector

6.10.1. Concept
6.10.2. Indications
6.10.3. Contraindications
6.10.4. Drug Administration and Monitoring
6.10.5. Concomitant use of Tocolytics in suspected Preterm Labor
6.10.6. Side Effects

Module 7. Pathology of the Placenta and Fetal Appendages. Obstetric Accidents

7.1. Placenta Accrete

7.1.1. Definition and Forms of Placenta Accrete

7.1.1.1. Placenta Accreta
7.1.1.2. Placenta Increta
7.1.1.3. Placenta Percreta

7.1.2. Risk Factors
7.1.3. Morbimortality
7.1.4. Diagnosis
7.1.5. Clinical Management and Delivery of Pregnant Women with Placental Accreta

7.2. Placenta Previa

7.2.1. Concept
7.2.2. Classification
7.2.3. Risk Factors
7.2.4. Morbimortality
7.2.5. Diagnosis
7.2.6. Management of gestation and delivery of the pregnant woman with placenta previa

7.3. Placental Morphological and Functional Abnormalities

7.3.1. Size Alterations
7.3.2. Morphological Changes

7.3.2.1. Bilobed Placenta
7.3.2.2. Circumvallate Placenta
7.3.2.3. Placenta Succenturiata
7.3.2.4. Espuria

7.3.3. Placental Insufficiency

7.4. Umbilical Cord Anomalies

7.4.1. Variants of Umbilical Cord Length and its Complications: Knots
7.4.2. Umbilical cord anomalies in relation to presentation

7.4.2.1. Procubitus
7.4.2.2. Laterocidence
7.4.2.3. Prolapses

7.4.2.3.1. Causes
7.4.2.3.2. Action to be taken in case of Cord Prolapse

7.4.3. Placental Insertion Abnormalities

7.4.3.1. Velamentous Insertion
7.4.3.2. Marginal Insertion
7.4.3.3. Previous Vasa

7.4.4. Vascular Anomalies

7.4.4.1. Thrombosis
7.4.4.2. Hematomas
7.4.4.3. The Single Umbilical Artery

7.5. Alterations of the Amniotic Membranes

7.5.1. Amnion Nodosum
7.5.2. Amniotic Bands
7.5.3. Extramembranous Pregnancy
7.5.4. Premature rupture of membranes and chorioamnionitis

7.6. Abnormalities of amniotic fluid

7.6.1. Default: Oligohydramnios and Anhydramnios

7.6.1.1. Concept and Epidemiology
7.6.1.2. Etiological Factors
7.6.1.3. Diagnosis
7.6.1.4. Effects on the Fetus and Neonate
7.6.1.5. Clinical Management and Treatment

7.6.2. In Excess: Polyhydramnios

7.6.2.1. Concept and Epidemiology
7.6.2.2. Etiological Factors
7.6.2.3. Diagnosis
7.6.2.4. Effects on the Fetus and Neonate
7.6.2.5. Clinical Management and Treatment. Delivery Assistance

7.7. Uterine Rupture.

7.7.1. Concept
7.7.2. Types
7.7.3. Risk Factors
7.7.4. Clinical Diagnosis
7.7.5. Treatment

7.8. Premature Detachment of a Normally Positioned Placenta

7.8.1. Concept
7.8.2. Risk Factors
7.8.3. Clinical Diagnosis
7.8.4. Clinical Management

7.9. Amniotic Fluid Embolism

7.9.1. Concept
7.9.2. Risk Factors
7.9.3. Pathophysiology
7.9.4. Clinical Symptoms
7.9.5. Diagnosis and Treatment

7.10. Shoulder Dystocia

7.10.1. Concept
7.10.2. Risk Factors
7.10.3. Diagnosis
7.10.4. Delivery Method case of Placental Abruption

7.10.4.1. Primary Level Techniques
7.10.4.2. Secondary Level Techniques
7.10.4.3. Tertiary Level Techniques

7.10.5. Postnatal Care and Assessment

Module 8. Variations in Normal Delivery and the Onset of Labor. Mother Carrier of Group B Streptococcus

8.1. Instrumental Delivery.

8.1.1. Concept
8.1.2. Indications
8.1.3. Contraindications
8.1.4. Criteria for using the Different Instruments

8.1.4.1. Forceps
8.1.4.2. Thierry Spatulas
8.1.4.3. Cupping

8.2. Breech Delivery

8.2.1. Concept
8.2.2. Classification
8.2.3. Etiology
8.2.4. Diagnosis
8.2.5. Vaginal Delivery Criteria and Management

8.3. Vaginal Delivery after Cesarean Section

8.3.1. Choice of Route of Delivery
8.3.2. Contraindications for Vaginal Delivery with Previous Cesarean Section
8.3.3. Planned Cesarean
8.3.4. Labor Induction

8.4. Cervical Ripening and Induction of Labor

8.4.1. Concept
8.4.2. Indications
8.4.3. Contraindications
8.4.4. Risks from Induction
8.4.5. Methods to Labor

8.5. Fetal Hydrops 

8.5.1. Concept 

8.5.1.1. Immune Hydrops 
8.5.1.2. Non-Immune Hydrops 

8.5.2. Pathophysiology
8.5.3. Diagnosis
8.5.4. Clinical Management

8.6. Mother Carrying Group B streptococci (SGB)

8.6.1. Concept 
8.6.2. Sample Collecting and Screening
8.6.3. Treatment
8.6.4. Management of Newborns of Mothers who are Carriers of GBS

8.7. Cesarean Section

8.7.1. Indications
8.7.2. Classification
8.7.3. Cesarean Section Considerations
8.7.4. Surgical Technique
8.7.5. Post-Operative Care

8.8. External Cephalic Version

8.8.1. Concept
8.8.2. Indications
8.8.3. Contraindications
8.8.4. Complete Technique and Procedure
8.8.5. Complications

8.8.5.1. Pharmacological Methods.
8.8.5.2. Non-Pharmacological Methods.

8.9. Premature Rupture of Membranes

8.9.1. Etiology
8.9.2. Diagnosis
8.9.3. Preterm Premature Rupture of Membranes
8.9.4. Full-term Premature Rupture of Membranes

8.10. Obstetric Anal Sphincter Injuries

8.10.1. Prevention
8.10.2. Classification

8.10.2.1. Third Degree Tear
8.10.2.2. Fourth Degree Tear

8.10.3. Reparation of Perineal Tears
8.10.4. Follow-up and Delivery after Anal Sphincter Injury

Module 9. Endocrine Problems during Pregnancy. Gynecologic Cancer and Pregnancy, Hypertensive States of Pregnancy

9.1. Thyroid Pathology and Gestation

9.1.1. Hypothyroidism

9.1.1.1. Diagnosis
9.1.1.2. Clinical Symptoms
9.1.1.3. Etiology
9.1.1.4. Clinical Management

9.1.2. Hyperthyroidism and Thyrotoxicosis

9.1.2.1. Diagnosis
9.1.2.2. Clinical Symptoms
9.1.2.3. Etiology
9.1.2.4. Clinical Management

9.1.3. Treatment during Gestation
9.1.4. Effects on the Fetus

9.2. Diabetes Mellitus and Pregnancy

9.2.1. Pregestational Management
9.2.2. Gestational Screening.
9.2.3. Criteria for the Termination of Pregnancy
9.2.4. Considerations during Labor
9.2.5. Newborn from a Mother with Diabetes Mellitus

9.3. Gestational Diabetes

9.3.1. Concept
9.3.2. Risk Factors
9.3.3. Diagnosis and Screening Protocol
9.3.4. Gestational Screening
9.3.5. Criteria for the Termination of Pregnancy
9.3.6. Clinical Management during Labor and Post-partum
9.3.7. Newborn from a Mother with Gestational Diabetes

9.4. Obesity and Pregnancy

9.4.1. Definition and Classification of Obesity
9.4.2. Impact of Obesity on Gestation
9.4.3. repercussion of Gestation on Obesity
9.4.4. Obese Women and the Postpartum Period

9.5. Breast Cancer and Pregnancy

9.5.1. Concept and Epidemiology
9.5.2. Diagnosis
9.5.3. Treatment
9.5.4. Prognosis

9.6. Cervical Cancer and Pregnancy

9.6.1. Concept and Epidemiology
9.6.2. Cytology in Gestation
9.6.3. Colposcopy in Gestation
9.6.4. Diagnosis and Treatment

9.7. Ovarian Cancer and Pregnancy

9.7.1. Concept and Epidemiology
9.7.2. Clinical Symptoms
9.7.3. Diagnosis
9.7.4. Treatment

9.8. Pregnancy Hypertensive States I

9.8.1. Concept
9.8.2. Classification of Hypertension in Pregnancy
9.8.3. Determination of the Degree of Severity
9.8.4. Prediction and Prevention
9.8.5. Treatment and Clinical Management
9.8.6. Criteria for the Termination of Pregnancy

9.9. Pregnancy Hypertensive states II

9.9.1. Eclampsia

9.9.1.1. Diagnosis
9.9.1.2. Clinical Management and Treatment

9.9.2. HELLP Syndrome

9.9.2.1. Diagnosis
9.9.2.2. Clinical Management and Treatment

9.9.3. Subsequent Follow-up of Pregnant Women with Hypertension Problems.

9.10. Antepartum Fetal Death

9.10.1. Concept
9.10.2. Classification
9.10.3. Etiological Factors
9.10.4. Diagnosis
9.10.5. Clinical and Psychological Management
9.10.6. Follow-up Genetic Counseling

Module 10. Pathology of Puerperium. Psychological Issues during the Postpartum Period. Cardiopulmonary Resuscitation in Pregnant Women and Neonates.

10.1. Postpartum Infection.

10.1.1. Concept and Etiology
10.1.2. Risk Factors
10.1.3. Forms of Propagation
10.1.4. Clinical Forms
10.1.5. Clinical Symptoms
10.1.6. Treatment and Prophylaxis

10.2. Postpartum Hemorrhage

10.2.1. Concept
10.2.2. Etiology

10.2.2.1. Uterine Tone
10.2.2.2. Obstetric Trauma and Uterine Inversion
10.2.2.3. Fabric
10.2.2.4. Coagulation Problems

10.2.3. Treatment

10.3. Main problems in breastfeeding I

10.3.1. Cracked Nipples
10.3.2. Mammary Ingurgitation and Obstruction
10.3.3. Eczema and Candidiasis of the Nipple
10.3.4. Hypogalactia

10.4. Main problems in breastfeeding II

10.4.1. Acute Mastitis

10.4.1.1. Definition, Etiology and Clinical Manifestations
10.4.1.2. Prevention
10.4.1.3. Treatment
10.4.1.4. Complications

10.5. Psychological Issues during the Postpartum Period

10.5.1. Maternity Blues or Postpartum Depression
10.5.2. Postpartum Depression

10.5.2.1. Concept 
10.5.2.2. Risk Factors
10.5.2.3. Prevention
10.5.2.4. Treatment

10.5.3. Puerperal Psychosis

10.5.3.1. Concept
10.5.3.2. Risk Factors
10.5.3.3. Prevention
10.5.3.4. Treatment

10.6. Perinatal Bereavement

10.6.1. Concept
10.6.2. Clinical Manifestations
10.6.3. Types of Grief
10.6.4. Phases of Perinatal Bereavement
10.6.5. Psychological Handling

10.7. Post Dural Puncture Headache

10.7.1. Concept
10.7.2. Differential Diagnosis
10.7.3. Treatment and Prophylaxis
10.7.4. Complications

10.8. Cardiopulmonary Resuscitation in Pregnant Women

10.8.1. Main Causes of Cardiorespiratory Arrest in Pregnant Women
10.8.2. Algorithm for Cardiopulmonary Resuscitation
10.8.3. Pregnancy-specific Considerations
10.8.4. Fetal Extraction

10.9. Neonatal Cardiopulmonary Resuscitation

10.9.1. Main Causes of Cardio-Respiratory in Neonates
10.9.2. Algorithm for Cardiopulmonary Resuscitation
10.9.3. Neuroprotection and Hypothermia in Infants

10.9.3.1. Definition and Mechanism of Action of Hypothermia
10.9.3.2. Inclusion and Exclusion Criteria
10.9.3.3. Treatment Phases and Cooling
10.9.3.4. Limitation of Therapeutic Exercise in Newborns with Hypoxic-Ischemic Encephalopathy

A unique, key, and decisive training experience to boost your professional development”